TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
TNXP

Tonix Pharmaceuticals Holding Corp

Healthcare · Biotechnology

9.90$ +1.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow TNXP
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-2,284,000,000.00 -2,126,400,000.00 -932,875,000.00 -191,280,000.00 -141,005,882.35 -10,630,677.29 -328,592.69 -134,242.41 -335,717.46 -12,871.04 -82.74 -11.73
3,600,000.00 8,050,000.00 5,150,000.00 700,000.00 317,647.06 10,358.57 182.68 88.84 4,290.07 541.45 4.65 0.23
308,800,000.00 219,450,000.00 81,650,000.00 17,900,000.00 9,570,588.24 580,478.09 19,458.73 14,034.18 37,367.75 1,170.35 6.49 0.71
308,800,000.00 219,450,000.00 84,975,000.00 17,900,000.00 9,570,588.24 580,478.09 28,660.35 19,364.30 37,367.75 – – –
104,400,000.00 48,800,000.00 -51,950,000.00 1,350,000.00 2,570,588.24 180,079.68 -16,008.12 10,271.13 -6.85 -4.42 7.84 1.00
31,900,000.00 11,900,000.00 1,650,000.00 50,000.00 35,294.12 6,772.91 57,943.17 62,730.08 164,847.47 996.21 0.16 0.40
-39,200,000.00 -1,208,550,000.00 414,850,000.00 71,690,000.00 -35,294.12 -6,772.91 -57,943.17 -62,730.08 -164,847.47 -3,668.14 -0.16 -0.53
0.00 0.00 0.00 0.00 19,211,764.71 985,657.37 3,051.42 – 22,799.33 – – –
5,349,700,000.00 2,384,700,000.00 4,175,000.00 740,000.00 138,464,705.88 5,147,011.95 9,201.62 5,330.11 -161,776.29 -1,762.15 0.00 -1.62
-28,000,000.00 – – – – – – – 0.00 1,128.33 -3.19 -1.13
5,321,700,000.00 2,384,700,000.00 512,450,000.00 185,190,000.00 138,464,705.88 5,147,011.95 832,916.10 377,526.47 300,763.52 4,607.82 183.17 25.21
2,998,200,000.00 -950,450,000.00 -5,850,000.00 65,550,000.00 -2,652,941.18 -5,492,031.87 446,271.99 180,498.90 -200,054.78 -11,939.56 100.27 12.94
-2,315,900,000.00 -2,138,300,000.00 -934,525,000.00 -191,330,000.00 -141,041,176.47 -10,637,450.20 -386,535.86 -196,972.50 -500,564.93 -13,867.26 -82.90 -12.13

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?